Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis.

Bentley, Siân; Davies, Jane C; Gastine, Silke; Donovan, Jackie; Standing, Joseph F

Bentley, Siân; Davies, Jane C; Gastine, Silke; Donovan, Jackie; Standing, Joseph F.

Afiliação

Bentley S; Pharmacy Department, Royal Brompton Hospital, London, UK.
Davies JC; National Heart and Lung Institute, Imperial College London, London, UK.
Gastine S; National Heart and Lung Institute, Imperial College London, London, UK.
Donovan J; Paediatric Respiratory Medicine Department, Royal Brompton Hospital, London, UK.
Standing JF; Infection, Immunity and Inflammation, Great Ormond Street Institute of Child Health, University College London, London, UK.

J Antimicrob Chemother ; 76(12): 3247-3254, 2021 11 12.

Article em En | MEDLINE | ID: mdl-34458906

Assuntos

Fibrose Cística; Adolescente; Criança; Fibrose Cística/complicações; Fibrose Cística/tratamento farmacológico; Monitoramento de Medicamentos; Humanos; Comprimidos; Triazóis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Cística Tipo de estudo: Guideline Limite: Adolescent / Child / Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google